The starting dose of Repaglinide Tablets in clinical practice is generally recommended to be 0.5mg, the maximum recommended single dose is 4mg, and the total daily dose is not recommended to be more than 16mg.The dosage of Repaglinide Tablets varies from person to person, and it is recommended that patients take the drug according to the doctor’s instructions. Clinically, Repaglinide tablets are mainly used for the treatment of type 2 diabetes mellitus. In addition, if metformin alone is not effective in controlling the symptoms of hyperglycemia in patients, this product can be combined with metformin, which has a better efficacy. The dose of metformin in combination can be the same as when taken alone, while the starting dose of Repaglinide tablets is recommended to be 0.5mg before meals. It is worth noting that the dosage of each drug should be adjusted by a medical professional according to the patient’s blood glucose, whether used alone or in combination. In the process of clinical application of Repaglinide tablets, the common adverse reactions are hypoglycemia, occasional vomiting, liver dysfunction, allergic reactions (such as itching, urticaria) and other symptoms. This product is contraindicated in people who are allergic to this product and in patients with type 1 diabetes mellitus, severe hepatic dysfunction, C-peptide negative diabetes mellitus, and diabetic ketoacidosis. Note: Repaglinide tablets are prescription drugs, patients need to rely on a prescription order issued by a doctor to buy, do not self-medication.